Search research articles
Contact Us
Filters
Showing results (1-10 of 134) with videos related to
Page
of 14
Sort By:
International Journal of Technology Assessment in Health Care
|
September 28, 2004
Using decision modeling to determine pricing of new pharmaceuticals: the case of neurokinin-1 receptor antagonist antiemetics for cancer chemotherapy
George Dranitsaris, Pauline Leung
Applied Health Economics and Health Policy
|
October 3, 2014
Health technology assessment of cancer drugs in Canada, the United Kingdom and Australia: should the United States take notice?
George Dranitsaris, George Papadopoulos
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 28, 2012
Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients
George Dranitsaris, Eleftheria Hatzimichael
Current Oncology (Toronto, Ont.)
|
November 10, 2022
Impact of Regulatory Approval Status on CADTH Reimbursement of Oncology Drugs and Role of Real-World Evidence on Conditional Approvals from 2019 to 2021
Catherine Lau, George Dranitsaris
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 30, 2014
Risk prediction models for chemotherapy-induced nausea and vomiting: almost ready for prime time?
George Dranitsaris, Mark Clemons
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 26, 2010
Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis
George Dranitsaris, Haytham Khoury
Applied Health Economics and Health Policy
|
June 30, 2009
Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis
George Dranitsaris, Sanjay Mehta
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 28, 2013
Full-dose chemotherapy in early stage breast cancer regardless of absolute neutrophil count and without G-CSF does not increase chemotherapy-induced febrile neutropenia
James A Chiarotto, George Dranitsaris
Journal of Evaluation in Clinical Practice
|
January 22, 2014
Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost
George Dranitsaris, Anne K Ellis
Breast Cancer Research and Treatment
|
September 14, 2014
Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine
George Dranitsaris, Mario E Lacouture
Page
of 14
Search research articles
Search
Showing results (1-10 of 134) with videos related to
Sort By:
Page
of 14
International Journal of Technology Assessment in Health Care
|
September 28, 2004
Using decision modeling to determine pricing of new pharmaceuticals: the case of neurokinin-1 receptor antagonist antiemetics for cancer chemotherapy
George Dranitsaris, Pauline Leung
Applied Health Economics and Health Policy
|
October 3, 2014
Health technology assessment of cancer drugs in Canada, the United Kingdom and Australia: should the United States take notice?
George Dranitsaris, George Papadopoulos
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 28, 2012
Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients
George Dranitsaris, Eleftheria Hatzimichael
Current Oncology (Toronto, Ont.)
|
November 10, 2022
Impact of Regulatory Approval Status on CADTH Reimbursement of Oncology Drugs and Role of Real-World Evidence on Conditional Approvals from 2019 to 2021
Catherine Lau, George Dranitsaris
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 30, 2014
Risk prediction models for chemotherapy-induced nausea and vomiting: almost ready for prime time?
George Dranitsaris, Mark Clemons
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 26, 2010
Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis
George Dranitsaris, Haytham Khoury
Applied Health Economics and Health Policy
|
June 30, 2009
Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis
George Dranitsaris, Sanjay Mehta
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 28, 2013
Full-dose chemotherapy in early stage breast cancer regardless of absolute neutrophil count and without G-CSF does not increase chemotherapy-induced febrile neutropenia
James A Chiarotto, George Dranitsaris
Journal of Evaluation in Clinical Practice
|
January 22, 2014
Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost
George Dranitsaris, Anne K Ellis
Breast Cancer Research and Treatment
|
September 14, 2014
Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine
George Dranitsaris, Mario E Lacouture
Page
of 14